CSpace  > 系统科学研究所
An MSE-reduced estimator for the response proportion in a two-stage clinical trial
Li, Qizhai
2011-05-01
发表期刊PHARMACEUTICAL STATISTICS
ISSN1539-1604
卷号10期号:3页码:277-279
摘要Two-stage design is very useful in clinical trials for evaluating the validity of a specific treatment regimen. When the second stage is allowed to continue, the method used to estimate the response rate based on the results of both stages is critical for the subsequent design. The often-used sample proportion has an evident upward bias. However, the maximum likelihood estimator or the moment estimator tends to underestimate the response rate. A mean-square error weighted estimator is considered here; its performance is thoroughly investigated via Simon's optimal and minimax designs and Shuster's design. Compared with the sample proportion, the proposed method has a smaller bias, and compared with the maximum likelihood estimator, the proposed method has a smaller mean-square error. Copyright (C) 2010 John Wiley & Sons, Ltd.
关键词truncated binomial distribution clinical trial MLE mean-square error
DOI10.1002/pst.414
语种英语
WOS研究方向Pharmacology & Pharmacy ; Mathematics
WOS类目Pharmacology & Pharmacy ; Statistics & Probability
WOS记录号WOS:000290626600012
出版者WILEY-BLACKWELL
引用统计
文献类型期刊论文
条目标识符http://ir.amss.ac.cn/handle/2S8OKBNM/12891
专题系统科学研究所
通讯作者Li, Qizhai
作者单位CAS, Acad Math & Syst Sci, Key Lab Syst & Control, Beijing, Peoples R China
推荐引用方式
GB/T 7714
Li, Qizhai. An MSE-reduced estimator for the response proportion in a two-stage clinical trial[J]. PHARMACEUTICAL STATISTICS,2011,10(3):277-279.
APA Li, Qizhai.(2011).An MSE-reduced estimator for the response proportion in a two-stage clinical trial.PHARMACEUTICAL STATISTICS,10(3),277-279.
MLA Li, Qizhai."An MSE-reduced estimator for the response proportion in a two-stage clinical trial".PHARMACEUTICAL STATISTICS 10.3(2011):277-279.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Li, Qizhai]的文章
百度学术
百度学术中相似的文章
[Li, Qizhai]的文章
必应学术
必应学术中相似的文章
[Li, Qizhai]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。